Weiland O - Search Results

1

[Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C].

Weiland O, Norkrans G, Frydén A, Braconier JH. Weiland O, et al. Lakartidningen. 1995 May 3;92(18):1920-2. Lakartidningen. 1995. PMID: 7746045 Swedish. No abstract available.

2

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.

Reichard O, Norkrans G, Frydén A, Braconier JH, Sönnerborg A, Weiland O. Reichard O, et al. Among authors: weiland o. Lancet. 1998 Jan 10;351(9096):83-7. doi: 10.1016/s0140-6736(97)06088-1. Lancet. 1998. PMID: 9439491 Clinical Trial.

3

Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.

Weiland O, Braconier JH, Frydén A, Norkrans G, Reichard O, Uhnoo I. Weiland O, et al. Scand J Infect Dis. 1999;31(2):115-8. doi: 10.1080/003655499750006119. Scand J Infect Dis. 1999. PMID: 10447316 Clinical Trial.

4

[Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].

Wejstål R, Fischler B, Glaumann H, Norkrans G, Reichard O, Sönnerborg A, Uhnoo I, Weiland O. Wejstål R, et al. Among authors: weiland o. Lakartidningen. 1999 Nov 3;96(44):4795-8, 4800. Lakartidningen. 1999. PMID: 10584541 Swedish. No abstract available.

5

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience.

Weiland O, Schvarcz R, Wejstål R, Norkrans G, Frydén A. Weiland O, et al. J Hepatol. 1990;11 Suppl 1:S57-62. doi: 10.1016/0168-8278(90)90165-n. J Hepatol. 1990. PMID: 2127789 Clinical Trial.

6

Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.

Reichard O, Glaumann H, Norkrans G, Wejstål R, Fryden A, Schvarcz R, Weiland O. Reichard O, et al. Among authors: weiland o. Liver. 1994 Aug;14(4):169-74. doi: 10.1111/j.1600-0676.1994.tb00070.x. Liver. 1994. PMID: 7526108

7

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment.

Reichard O, Glaumann H, Frydén A, Norkrans G, Schvarcz R, Sönnerborg A, Yun ZB, Weiland O. Reichard O, et al. Among authors: weiland o. Hepatology. 1995 Apr;21(4):918-22. Hepatology. 1995. PMID: 7705800

8

Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.

Yun ZB, Reichard O, Chen M, Lundeberg J, Norkrans G, Fryden A, Sönnerborg A, Weiland O. Yun ZB, et al. Among authors: weiland o. Scand J Infect Dis. 1994;26(3):263-70. doi: 10.3109/00365549409011794. Scand J Infect Dis. 1994. PMID: 7939425

9

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.

Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G. Weiland O, et al. Scand J Infect Dis. 1995;27(5):319-24. Scand J Infect Dis. 1995. PMID: 8588128 Clinical Trial.

10

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.

Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G. Weiland O, et al. Scand J Infect Dis. 1995;27(4):319-24. Scand J Infect Dis. 1995. Corrected and republished in: Scand J Infect Dis. 1995;27(5):319-24. PMID: 8658063 Corrected and republished. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters